PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27990118-2	2016	Many studies implicate polymorphisms in genes encoding the enzymes responsible for leukotriene synthesis and intracellular signaling through activation of seven transmembrane domain receptors, such as the cysteinyl leukotriene 1 (CYSLTR1) and 2 (CYSLTR2) receptors.	Leukotrienes	83-94	cysteinyl leukotriene receptor 2	Homo sapiens	246-253	
25760841-7	2015	CONCLUSIONS: CysLTR-1 and CysLTR-2 are highly expressed in the adenoid tissues from children with AH, suggesting that leukotrienes are involved in the pathogenesis of AH.	Leukotrienes	118-130	cysteinyl leukotriene receptor 2	Homo sapiens	26-34	
19077707-7	2009	Variants in ALOX5, LTA4H, LTC4S, ABCC1, CYSLTR2, and SLCO2B1 contribute to variability in response to leukotriene modifiers.	Leukotrienes	102-113	cysteinyl leukotriene receptor 2	Homo sapiens	40-47	
24361619-9	2014	CONCLUSIONS: These results indicate that mAbLTC and scFvLTC neutralize the biological activities of LTs by competing their binding to CysLT1R and CysLT2R.	Leukotrienes	100-103	cysteinyl leukotriene receptor 2	Homo sapiens	146-153	
17460547-10	2007	CYSLTR2 and ALOX5 polymorphisms may predispose a minority of individuals to excessive cysteinyl-leukotriene concentrations, yielding a distinct asthma phenotype most likely to respond to leukotriene modifier pharmacotherapy.	Leukotrienes	96-107	cysteinyl leukotriene receptor 2	Homo sapiens	0-7	
17394438-1	2007	The 5-Lipoxygenase pathway results in the formation of leukotrienes, including leukotriene B(4) (LTB(4)), 5-oxo-6E,8Z,11Z,14Z-eicosatetranoic acid and the cysteinyl leukotrienes (LTC(4), LTD(4) and LTE(4)) and activates all four leukotriene receptors, BLT1, BLT2, cysLT(1) and cysLT(2).	Leukotrienes	55-67	cysteinyl leukotriene receptor 2	Homo sapiens	277-285	
12816882-9	2003	CONCLUSIONS: Our data raise the possibility that MPhi-derived LTs differentially activate cysLT2-Rs via paracrine stimulation and cysLT1-Rs via autocrine and paracrine stimulation during inflammation and atherogenesis.	Leukotrienes	62-65	cysteinyl leukotriene receptor 2	Homo sapiens	90-96	
11093801-6	2000	The leukotriene analog BAY u9773, reported to be a dual CysLT(1)/CysLT(2) antagonist, was found to be an antagonist at CysLT(1) sites but acted as a partial agonist at this new receptor.	Leukotrienes	4-15	cysteinyl leukotriene receptor 2	Homo sapiens	65-73